Products based on monoclonal antibodies
MediaPharma is committed to developing innovative products based on monoclonal antibodies designed to safely and effectively treat patients with cancer and improve patient outcomes.
|
Product |
Description |
Product Type |
Status |
|
MP-RM-1 |
Receptor tyrosine kinase |
Mouse antibody |
Preclinical |
|
MP-AA-1 |
Matricellular protein ligand |
Mouse antibody |
Preclinical |
|
MP-PN-1 |
Cell surface component |
Mouse antibody |
Preclinical |
|
MP-PN-2 |
Cell surface component |
Mouse antibody |
Research |
Last updated: 01/12/2009 14:02
MediaPharma S.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.